Apotex Health Corp. (TSX:APTX)
Canada · Delayed Price · Currency is CAD 33.25
-0.74 (-2.18%)
At close: Sep 18, 2026
Apotex Health Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Apotex Health stock has a consensus rating of "Strong Buy" and an average price target of $41.23. The average 1-year stock price forecast is 24.00% higher than the current stock price, while the lowest is $40.00 (+20.30%) and the highest is $44.30 (+33.23%).
Price Target: $41.23 (+24.00%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 13, 2026.
Analyst Ratings
The average analyst rating for Apotex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|
| Strong Buy | 6 | 7 | 7 |
| Buy | 7 | 7 | 5 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 13 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| CIBC | CIBC | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +20.30% | Aug 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $42.00 | Buy | Maintains | $42.00 | +26.32% | Aug 13, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +20.30% | Aug 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $43.00 | Buy | Maintains | $43.00 | +29.32% | Aug 13, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $39.00 → $43.00 | Buy | Reiterates | $39.00 → $43.00 | +29.32% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
3.40B
from 3.49B
Decreased by -2.69%
Revenue Next Year
3.68B
from 3.40B
Increased by 8.42%
EPS This Year
2.19
EPS Next Year
2.39
from 2.19
Increased by 9.26%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.